Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Shiloh M. Martin · SciRah

Researcher profile · Semantic Scholar

Shiloh M. Martin

Share profile

Shiloh M. Martin — researcher profile on SciRah

h-index: 7
Works: 16
Citations: 150

Most-cited papers

Efficacy, Biodistribution, and Pharmacokinetics of CD22-Targeted Pegylated Liposomal Doxorubicin in a B-cell Non–Hodgkin's Lymphoma Xenograft Mouse Model
J. Tuscano, Shiloh M. Martin, Yunpeng Ma, W. Zamboni +1 more
2010Clinical Cancer Research51 citations
Semantic Scholar
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
R. O'Donnell, Shiloh M. Martin, Yunpeng Ma, W. Zamboni +1 more
2009Investigational new drugs23 citations Open access
Semantic Scholar
Peptide Length Variants p2Ca and QL9 Present Distinct Conformations to Ld-Specific T Cells1
T. Hornell, Shiloh M. Martin, N. Myers, J. Connolly
2001Journal of Immunology16 citations Open access
Semantic Scholar
The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone
J. Tuscano, Yunpeng Ma, Shiloh M. Martin, J. Kato +1 more
2011Cancer Immunology and Immunotherapy14 citations Open access
Semantic Scholar
Imaging and Pharmacokinetics of 64Cu-DOTA-HB22.7 Administered by Intravenous, Intraperitoneal, or Subcutaneous Injection to Mice Bearing Non-Hodgkin’s Lymphoma Xenografts
Shiloh M. Martin, R. O'Donnell, D. Kukis, C. Abbey +3 more
2009Molecular Imaging and Biology13 citations
Semantic Scholar
The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination
Laura F. Newell, J. Tuscano, Yunpeng Ma, Shiloh M. Martin +1 more
201012 citations
Semantic Scholar
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
Shiloh M. Martin, E. Churchill, H. McKnight, C. M. Mahaffey +3 more
2011Journal of Hematology & Oncology7 citations Open access
Semantic Scholar
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2
V. Jacovas, M. Zelnick, Shannon M. McNulty, Justyne E. Ross +20 more
2025Genetics in Medicine5 citations Open access
Semantic Scholar
B-CELL LYMPHOMA LINE (RAJI) VIABILITY AND SURFACE MARKER EXPRESSION MINIMALLY AFFECTED BY 20- AND 25-GAUGE VITRECTOMY SYSTEMS ANALYZED BY FLOW CYTOMETRY
Rupan Trikha, Cecilia C. S. Yeung, S. Modjtahedi, Shiloh M. Martin +2 more
2010Retina4 citations
Semantic Scholar
B cell reductive therapy in the treatment of autoimmune diseases: A focus on monoclonal antibody treatment of rheumatoid arthritis
J. Tuscano, Shiloh M. Martin, Kyle R Song, T. Wun
2005Hematology3 citations Open access
Semantic Scholar
The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2
Vanessa C. Jacovas, Michelle Zelnick, Shannon M. McNulty, Justyne E. Ross +20 more
2025medRxiv2 citations Open access
Semantic Scholar
Recommendations from the ClinGen SCID VCEP: Implementation of ACMG/AMP Variant Curation Guidelines for Severe Combined Immunodeficiency Disease
V. Jacovas, M. Zelnick, M. Cowan, Rajarshi Ghosh +10 more
2023Clinical Immunology0 citations
Semantic Scholar
Anti-CD 22 Monoclonal Antibody Enhances Bortezomib-mediated Lymphomacidal Activity in a Sequence Dependent Manner Permalink
Shiloh M. Martin, E. Churchill, H. McKnight, C. M. Mahaffey +4 more
20120 citations
Semantic Scholar
Targeted Therapy Of Non-Hodgkin's Lymphoma Using The Anti-CD22 Monoclonal Antibody HB22.7
Shiloh M. Martin
20110 citations
Semantic Scholar
Intravenous, Intraperitoneal, and Subcutaneous Routes of Administering 64 Cu-DOTA-HB22.7 Display Equivalent Tumor Targeting Ability.
Shiloh M. Martin, R. O'Donnell, H. McKnight, Julie L. Sutcliff +1 more
20070 citations
Semantic Scholar
Distinct Conformations to L Peptide Length Variants p 2 Ca and QL 9
J. Connolly, T. Hornell, Shiloh M. Martin, N. Myers
20010 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Tuscano×9
Invite
J. Tuscano — researcher profile on SciRah
R. O'Donnell×7
Invite
R. O'Donnell — researcher profile on SciRah
Yunpeng Ma×6
Invite
Yunpeng Ma — researcher profile on SciRah
H. McKnight×4
Invite
H. McKnight — researcher profile on SciRah

×3

Invite

M. Hershfield — researcher profile on SciRah

Invite

I. Chinn — researcher profile on SciRah

Invite

W. Zamboni — researcher profile on SciRah

Invite

T. Hornell — researcher profile on SciRah

Invite

N. Myers — researcher profile on SciRah

Invite

J. Connolly — researcher profile on SciRah

E. Churchill×2

Invite

E. Churchill — researcher profile on SciRah

C. M. Mahaffey×2

Invite

C. M. Mahaffey — researcher profile on SciRah